# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Ascendiant Capital analyst Lucas Ward initiates coverage on Aclarion (NASDAQ:ACON) with a Buy rating and announces Price Tar...
https://register.epo.org/application?number=EP21157092
Aclarion, Inc., ("Aclarion" or the "Company") (NASDAQ:ACON, ACONW)))), a healthcare technology company that is ...